ZAS Corporation Launches Revolutionary Antibiotic Polymyxin B to Combat Multidrug-Resistant Infections in Bangladesh.
ZAS Corporation is proud to announce the successful launch of Polymyxin B, a groundbreaking antibiotic from our Critical Care division. This potent medication is specifically designed to target and treat serious infections caused by multidrug-resistant gram-negative bacteria, a major concern in healthcare today. The launch event was marked by a comprehensive Training Session for our […]